Walker Marlan D's Form 4 filing
TherapeuticsMD, Inc. (TXMD) · filed Apr 10, 2025
- Accession no.
- 0000905148-25-001190
- Filed
- Apr 10, 2025
- Trade date
- Apr 9-10, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.99K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walker Marlan DCIK 0001820187 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2025 | Common Stock | PPurchaseAcquired | +1,136 | $0.87 | +$988.32 | 71,982 | Direct | |
| Apr 10, 2025 | Common Stock | PPurchaseAcquired | +1,167 | $0.86 | +$1,003.62 | 73,149 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.